| 臺大學術典藏 |
2021-01-12T12:53:47Z |
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
|
SHANG-YI HUANG; Chen T.-Y.; Kuo C.-Y.; Chen Y.-C.; Lin S.-F.; Chang M.-C.; Lv X.; Yang B.; Chang C.-S. |
| 臺大學術典藏 |
2021-01-12T12:53:47Z |
Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry
|
Huang T.-C.; SHANG-YI HUANG; Yao M.; Lin C.-Y.; Hwang W.-L.; Gau J.-P.; Tan T.-D.; Wang P.-N.; Liu Y.-C.; Lin S.-C.; Kao R.-H.; Pei S.-N.; Yu M.-S.; Lin H.-Y.; Su Y.-C.; Chen C.-C.; Li S.-S.; Wu Y.-Y. |
| 臺大學術典藏 |
2021-01-12T12:53:46Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; SHANG-YI HUANG; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-12T12:53:46Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Huang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; SHANG-YI HUANG; Tseng M.-H.; Tien H.-F.; Chen R.-H. |
| 臺大學術典藏 |
2021-01-12T12:53:46Z |
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
|
Dimopoulos M.A.; Gay F.; Schjesvold F.; Beksac M.; Hajek R.; Weisel K.C.; Goldschmidt H.; Maisnar V.; Moreau P.; Min C.K.; Pluta A.; Chng W.-J.; Kaiser M.; Zweegman S.; Mateos M.-V.; Spencer A.; Iida S.; Morgan G.; Suryanarayan K.; Teng Z.; Skacel T.; Palumbo A.; Dash A.B.; Gupta N.; Labotka R.; Rajkumar S.V.; Bar D.; Basso A.; Fantl D.; He S.; Horvath N.; Lee C.; Rowlings P.; Taylor K.; Cochrane T.; Kwok F.; Ramanathan S.; Agis H.; Zojer N.; Kentos A.; Offner F.; Van Droogenbroeck J.; Wu K.L.; Maiolino A.; Martinez G.; Zanella K.; Capra M.; Araújo S.; Gregora E.; Pour L.; Scudla V.; Spicka I.; Abildgaard N.; Andersen N.; Jensen B.A.; Helleberg C.; Plesner T.; Salomo M.; Svirskaite A.; Delarue R.; Blau I.; Schieferdecker A.; Teleanu V.; Munder M.; Röllig C.; Salwender H.-J.; Fuhrmann S.; Weisel K.; Duerig J.; Zeis M.; Klein S.; Reimer P.; Schmidt C.; Scheid C.; Mayer K.; Hoffmann M.; Sosada M.; Dimopoulos A.; Delimpasi S.; Kyrtsonis M.-C.; Anagnostopoulos A.; Nagy Z.; Illés ?.; Egyed M.; Borbényi Z.; Mikala G.; Dally N.; Horowitz N.; Gutwein O.; Nemets A.; Vaxman I.; Shvetz O.; Trestman S.; Ruchlemer R.; Nagler A.; Tadmor T.; Rouvio O.; Preis M.; Cavo M.; De Rosa L.; Musto P.; Cafro A.; Tosi P.; Offidani M.; Corso A.; Rossi G.; Liberati A.M.; Bosi A.; Suzuki K.; Nakaseko C.; Ishikawa T.; Matsumoto M.; Nagai H.; Sunami K.; Chou T.; Akashi K.; Takezako N.; Hagiwara S.; Eom H.S.; Jo D.-Y.; Kim J.S.; Lee J.H.; Yoon S.S.; Yoon D.H.; Kim K.; Levin M.-D.; Vellenga E.; Minnema M.; Waage A.; Haukås E.; Grosicki S.; Pluta A.; Robak T.; Marques H.; Bergantim R.; Campilho F.; Chng W.J.; Goh Y.T.; McDonald A.; Rapoport B.; ?lvarez Rivas M.A.; De Arriba de La Fuente F.; González Montes Y.; Martin Sanchez J.; Mateos M.V.; Oriol Rocafiguera A.; Rosinol L.; San Miguel J.; Pérez de Oteyza J.; Encinas C.; Alegre-Amor A.; López-Guía A.; Axelsson P.; Carlson K.; Stromberg O.; Hansson M.; Hveding Blimark C.; Mueller R.; Chen C.-C.; Liu T.-C.; SHANG-YI HUANG; Wang P.-N.; Na Nakorn T.; Prayongratana K.; Unal A.; Goker H.; Sonmez M.; Korenkova S.; Chaidos A.; Oakervee H.; Sati H.; Benjamin R.; Wechalekar A.; Garg M.; Ramasamy K.; Cook G.; Chantry A.; Jenner M.; Buadi F.; Berryman R.; Janakiram M.; TOURMALINE-MM3 study group |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)?�a trial by the Asian Myeloma Network
|
Soekojo C.Y.; Kim K.; SHANG-YI HUANG; Chim C.-S.; Takezako N.; Asaoku H.; Kimura H.; Kosugi H.; Sakamoto J.; Gopalakrishnan S.K.; Nagarajan C.; Wei Y.; Moorakonda R.; Lee S.L.; Lee J.J.; Yoon S.-S.; Kim J.S.; Min C.K.; Lee J.-H.; Durie B.; Chng W.J. |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008??013
|
Chen C.-Y.; Sheng W.-H.; Tien F.-M.; Lee P.-C.; SHANG-YI HUANG; Tang J.-L.; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials
|
Dimopoulos M.A.; Moreau P.; Iida S.; SHANG-YI HUANG; Takezako N.; Chng W.J.; Zahlten-Kumeli A.; Sersch M.A.; Li J.; Huang M.; Lee J.H. |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
|
Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG; D?�Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. |
| 臺大學術典藏 |
2021-01-12T12:53:44Z |
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase?3 Study?�Asian Subgroup Analysis
|
SHANG-YI HUANG; Yoon S.-S.; Shimizu K.; Chng W.J.; Chang C.-S.; Wong R.S.-M.; Gao S.; Wang Y.; Gordon S.W.; Glennane A.; Min C.-K. |
| 臺大學術典藏 |
2021-01-12T12:53:44Z |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
|
SHANG-YI HUANG; Chang C.-S.; Tang J.-L.; Tien H.-F.; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; Chou W.-C.; Chung C.-Y.; Wang C.-H.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-12T12:53:44Z |
Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan
|
SHANG-YI HUANG; Tang J.-L.; Liang Y.-J.; Wang C.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:53:43Z |
Clonal disease of natural killer large granular lymphocytes in Taiwan
|
Chou W.-C.; Chiang I.-P.; Tang J.-L.; Su I.-J.; SHANG-YI HUANG; Chen Y.-C.; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; Shen M.-C.; Chuang S.-M.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:24Z |
Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
|
Sheu J.-C.; Lin Y.-W.; Chou H.-C.; Huang G.-T.; Lee H.-S.; Lin Y.-H.; SHANG-YI HUANG; Chen C.-H.; Wang J.-T.; Lee P.-H.; Lin J.-T.; Lu F.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-12T12:49:24Z |
Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years
|
SHANG-YI HUANG; Tang J.-L.; Jou S.-T.; Tsay W.; Hu C.-H.; Lin D.-T.; Lin K.-S.; Lin K.-S.; Wang C.-H.; Chen Y.-C.; Shen M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:23Z |
Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: Incidence, treatment, and prognosis
|
Chen C.-Y.; Chen Y.-C.; Tang J.-L.; Yao M.; SHANG-YI HUANG; Tsai W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:23Z |
Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23
|
Shiah H.-S.; Kuo Y.-Y.; Tang J.-L.; SHANG-YI HUANG; Yao M.; Tsay W.; Chen Y.-C.; Wang D.-T. C.-H. -au Shen, Lin K.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:23Z |
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: An useful salvage therapy
|
SHANG-YI HUANG; Yang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-12T12:49:22Z |
Nonirradiated NOD/SCID-Human Chimeric Animal Model for Primary Human Multiple Myeloma: A Potential in Vivo Culture System
|
SHANG-YI HUANG; Tien H.-F.; Su F.-H.; Hsu S.-M. |
| 臺大學術典藏 |
2021-01-12T12:49:22Z |
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
|
SHANG-YI HUANG; Tang J.-L.; Yao M.; Ko B.-S.; Hong R.-L.; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-12T12:49:21Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; SHANG-YI HUANG; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:21Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; SHANG-YI HUANG; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:21Z |
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy
|
Chen C.-Y.; Tang J.-L.; Hsueh P.-R.; Yao M.; SHANG-YI HUANG; Chen Y.-C.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tsai W.; Chang S.-C.; Tien H.-F.; Luh K.-T. |
| 臺大學術典藏 |
2021-01-12T12:49:20Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Yang P.-C.; Hsu C.-Y.; Tien H.-F.; Yu C.-W.; Tsay W.; Hsu S.-C.; Chou W.-C.; SHANG-YI HUANG; Yao M.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y. |
| 臺大學術典藏 |
2021-01-12T12:49:20Z |
Extramedullary plasmacytoma masquerading as Tolosa-Hunt syndrome: A case report
|
Ko S.; SHANG-YI HUANG; Liu C.-Y. |
